Showing results (1531-1540 of 1,725) with videos related to
Sort By:
Pageof 173
Pulmonary Circulation|February 13, 2019
Pathophysiology, incidence, management, and consequences of cardiac arrhythmia in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertensionMeghan M Cirulis, John J Ryan, Stephen L ArcherPulmonary Circulation|November 26, 2020
Association of plasma adiponectin with pulmonary hypertension, mortality and heart failure in African Americans: Jackson Heart StudySuvasini Lakshmanan, Matthew Jankowich, Wen-Chih Wu, et al.Pulmonary Circulation|November 26, 2020
Residence at moderately high altitude and its relationship with WHO Group 1 pulmonary arterial hypertension symptom severity and clinical characteristics: the Pulmonary Hypertension Association RegistryShoaib Fakhri, Kelly Hannon, Kelly Moulden, et al.Pulmonary Circulation|February 23, 2018
The serotonin hypothesis in pulmonary hypertension revisited: targets for novel therapies (2017 Grover Conference Series)Margaret Mandy R MacLeanPulmonary Circulation|November 5, 2020
Trichloroethylene increases pulmonary endothelial permeability: implication for pulmonary veno-occlusive diseaseJulien Caliez, Marianne Riou, Grégoire Manaud, et al.Pulmonary Circulation|June 9, 2021
Pulmonary arterial hypertension in pregnancy-a systematic review of outcomes in the modern eraTing-Ting Low, Nita Guron, Robin Ducas, et al.Pulmonary Circulation|October 28, 2021
Liver abnormalities in pulmonary arterial hypertensionNils P Nickel, Gian M Galura, Marc J Zuckerman, et al.Pulmonary Circulation|May 4, 2022
A second hit? Pulmonary arterial hypertension, BMPR2 mutation, and exposure to prescription amphetaminesHuzaifa A Jaliawala, Miloni Parmar, Katherine Summers, et al.Pulmonary Circulation|May 4, 2022
Building a dedicated pediatric pulmonary hypertension program: A consensus statement from the pediatric pulmonary hypertension networkStephanie S Handler, Nidhy P Varghese, Erika B Rosenzweig, et al.Pulmonary Circulation|May 4, 2022
Long-term safety of a structured transition protocol from parenteral prostanoids to selexipag in pulmonary arterial hypertensionYuichi Tamura, Asuka Furukawa, Yudai Tamura, et al.Pageof 173